Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system
- Resource Type
- Article
- Source
- In
Nanomedicine: Nanotechnology, Biology, and Medicine April 2018 14(3):1019-1031 - Subject
- Language
- ISSN
- 1549-9634